文献速递肾移植

美国肾移植三十年HLA匹配趋势、差异与临床意义

HLA Matching in US Kidney Transplantation over Three Decades: Trends, Disparities, and Clinical Implications.
PubMed 文献 · J Am Soc Nephrol · 2026-07-29

该研究基于1991至2023年美国移植受者科学登记数据,分析活体与 deceased 供肾移植中HLA匹配的时间趋势及种族和年龄亚组差异。结果显示零HLA-ABDR和零HLA-DR错配比例显著下降,儿童和少数族裔 deceased 供肾受者匹配率最低。尽管关联减弱,HLA匹配仍与更好移植物存活和再等待时更高计算Panel反应性抗体相关。

要点

  • 美国肾移植HLA匹配率自1991年显著下降,2023年零HLA-ABDR错配仅5%。
  • 儿童和少数族裔 deceased 供肾受者HLA匹配率最低。
  • HLA匹配仍与更好移植物存活相关,但近期时代获益幅度减弱。

核心结论

  • 过去三十年美国肾移植HLA匹配显著下降,儿童和少数族裔匹配率最低。
  • HLA匹配仍与更好移植物存活和再等待时更低致敏相关,但近期获益减弱。

研究设计与样本

  • 基于美国移植受者科学登记数据,纳入1991至2023年活体和 deceased 供肾移植。
  • 分析零HLA-ABDR和零HLA-DR错配的时间趋势及种族和年龄亚组差异。

主要发现

  • 2023年零HLA-ABDR错配移植为1145例(5%),零HLA-DR错配为3804例(16%)。
  • 1991年零HLA-ABDR错配为318例(11%),零HLA-DR错配为929例(32%)。
  • deceased 供肾移植趋势与分配政策变化间歇相关,活体供肾移植下降与生物学相关供者减少平行。
  • HLA错配程度越高,再等待时计算Panel反应性抗体显著更高。

临床怎么用

  • 临床应关注儿童和少数族裔肾移植受者的HLA匹配劣势。
  • 在分配政策评估中需重新考量HLA匹配策略对脆弱人群的支持。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: HLA matching in US kidney transplantation has declined markedly since 1991, with the lowest rates observed in pediatric and Black recipients. Despite attenuation, close HLA matching remains associated with better graft survival and lower sensitization at repeat waitlisting. Current policies may insufficiently support vulnerable populations, highlighting the need to reassess HLA matching strategies in allocation policy. BACKGROUND: HLA matching is associated with better allograft survival and reduced immunosuppression requirements in kidney transplantation. However, the effects of evolving US kidney allocation policies and changes in living donor demographics on the degree of HLA matching over time have not been characterized. METHODS: Using Scientific Registry of Transplant Recipients data from 1991 to 2023, we evaluated temporal trends in zero HLA-ABDR and zero HLA-DR mismatches among living and deceased donor kidney transplants, including across racial and age subgroups. We further examined associations between HLA mismatching and graft outcomes across transplant eras (1990s, 2000s, 2010s) and peak calculated panel reactive antibody at repeat waitlisting. RESULTS: The proportion of well-matched kidney transplants declined substantially over time. In 2023, 1145 (5%) and 3804 (16%) transplants had zero HLA-ABDR and zero HLA-DR mismatches, respectively, compared with 318 (11%) and 929 (32%) in 1991. Trends in deceased donor transplantation were intermittent and temporally aligned with allocation policy changes, whereas declines in living donor transplantation were continuous and paralleled reductions in biologically related donors. These patterns were consistent across racial and age groups, with the lowest rates observed among children and racial minority deceased donor kidney recipients. Although the associations are weaker in recent eras, HLA matching remained significantly associated with better graft survival, and greater HLA mismatching was associated with significantly higher calculated panel reactive antibody at repeat listing. CONCLUSIONS: HLA matching in US kidney transplantation has declined markedly over the past three decades, with children and racial minorities currently experiencing the lowest levels of matching. Well-matched transplants experience better graft longevity, but the magnitude of benefit has diminished in the most recent era.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Morford HJ, Tambur A, Hoffman W, et al. HLA Matching in US Kidney Transplantation over Three Decades: Trends, Disparities, and Clinical Implications. J Am Soc Nephrol. 2026. PMID: 42525732. doi:10.1681/ASN.0000001202

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。